
Human cytomegalovirus: pathogenesis, prevention, and treatment
Human cytomegalovirus (HCMV) infection remains a significant global health challenge, particularly for immunocompromised individuals and newborns. This comprehensive review synthesizes current knowledge on HCMV pathogenesis, prevention, and treatment strategies.
Human Cytomegalovirus (HCMV) – Revised - PMC
HCMV infections show low pathogenicity in healthy, immunocompetent individuals and cause only mild, if any, symptoms. HCMV leads to latent (persistent) infections with the possibility of recurrence with viral replication (with and without symptoms).
Human Cytomegalovirus Decreases Major Histocompatibility …
Mar 17, 2020 · We investigated the impact of HCMV infection on MHC class II in Kasumi-3 cells, a myeloid-progenitor cell line that endogenously expresses the MHC class II gene, HLA-DR. We observed a significant reduction in the expression of surface and total HLA-DR at 72 h postinfection (hpi) and 120 hpi in infected cells.
Human Cytomegalovirus Inhibits Major Histocompatibility …
Mar 3, 1998 · Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus that is able to persist for decades in its host. HCMV has evolved protean countermeasures for anti-HCMV cellular immunity that facilitate establishment of persistence.
Human Cytomegalovirus Disrupts the Major Histocompatibility …
Jan 19, 2011 · To cope with CD8 + T-cell responses, human cytomegalovirus (HCMV) encodes several posttranslational strategies inhibiting peptide transport and MHC I biogenesis which have been studied extensively in transfected cells. Here we analyzed assembly of the PLC in naturally HCMV-infected fibroblasts throughout the protracted replication cycle.
Human Cytomegalovirus (HCMV) | British Society for Immunology
Human cytomegalovirus (HCMV) is a beta-herpesvirus that causes lifelong infection in humans. HCMV has a prevalence of 55-100% within the human population, depending on different socioeconomic and geographical factors.
Human cytomegalovirus disrupts constitutive MHC class II …
Jul 1, 2002 · CD8(+) and CD4(+) T lymphocytes are important in controlling human CMV (HCMV) infection, but the virus has evolved protean mechanisms to inhibit MHC-based Ag presentation and escape T lymphocyte immunosurveillance.
The HCMV gene products US2 and US11 target MHC class I
Two HCMV proteins, US2 and US11, target newly synthesized MHC class I heavy chains for destruction via a pathway that involves ubiquitin-dependent retrograde transport, or "dislocation", of the heavy chains from the ER to the cytosol, where the proteins are degraded by proteasomes.
Classical and non-classical MHC I molecule manipulation by
Major histocompatibility complex (MHC) class I molecules represent a basic molecular framework that mediates the activation and function of cytotoxic effector cells of the adaptive and...
Human cytomegalovirus: pathogenesis, prevention, and …
Nov 25, 2024 · Human cytomegalovirus (HCMV) infection remains a significant global health challenge, particularly for immunocompromised individuals and newborns. This comprehensive review synthesizes current knowledge on HCMV pathogenesis, prevention, and …